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Antisera were raised to a synthetic peptide which represents the predicted C-terminal decapeptide of the c( subunit of the G-proteins Gq and GI 1. 
Competitive ELISA indicated that antiserum CQ2 displayed strong reactivity against this peptide. Antiserum CQ2 identified an apparently single 
polypeptide of 42 kDa which was expressed widely. The mobility of this polypeptide in SDS-PAGE was not modified by pretreatment of cells 
with pertussis toxin, indicating that it was not a substrate for this toxin. Furthermore, the levels and mobility of this polypeptide were unaltered 
by treatment of cells with cholera toxin, defining that it was not related to G,cc. 
G-protein; Inositol phosphate; Transmembrane signailing 
1. INTRODUCTION 
Whilst the molecular identity of the G-proteins 
regulating both receptor-mediated stimulation (G,) and 
inhibition (Gi2) of adenylyl cyclase are now firmly 
established it has been more difficult to identify 
positively the G-protein(s) responsible for receptor- 
linked phosphoinositide hydrolysis. The identification 
of G-proteins regulating adenylyl cyclase activity was 
promoted initially by the disruptive effect that both 
cholera and pertussis toxins had on receptor regulation 
of cyclic AMP generation [I] and subsequently con- 
firmed by the production of antisera directed against 
the two G-proteins which were able to interfere with the 
interactions of these G-proteins and relevant receptors 
[2-51. It was clear that receptors which cause an in- 
crease in the rate of production of water soluble inositol 
phosphates do so via a G-protein because of the effects 
both of pooriy hydrolysed analogues of GTP on the af- 
finity of agonist binding to such receptors, and of the 
synergistic effects of guanine nucleotides and receptor 
agonists on inositoi phosphate production in 
permeabilized cells [6]. However, as both cholera and 
pertussis toxins have little or no effect on this process in 
the vast majority of cells and tissues alternate strategies 
have been required to identify this G-protein(s). The re- 
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cent isolation of cDNA’s corresponding to novel G- 
protein O! subunits with unknown function and which 
do not have the sequence characteristics required for 
modification by pertussis toxin-catalysed ADP-ribo- 
sylation has provided a new impetus for studies in this 
field [7]. In this paper we report the generation and 
characteristics of an antiserum which shows high selec- 
tivity for the C-terminal decapeptide sequence of 
Gq/GI I. Re~onstitutive studies with G-protein contain- 
ing fractions from either brain or liver have indicated 
that this G-protein(s) can interact with and activate 
phospholipase C 01 [8,9]. 
2. MATERIALS AND METHODS 
2. I Rntisrro 
Antiserum CQ2 was generated in a New Zealand White rabbit 
which was immunized with a conjugate of a synthetic peptide 
QLNLKEYNLV-CQOH and keyhole limpet haemocyanin (KLH) 
(Calbiochem). An additional cysteine, to assist coupling of the pep- 
tide to the protein, was placed at the N-terminal sequence of the pep- 
tide, which is equivalent to the C-terminal decapeptide predicted foi 
both Gq and Gl I. Coupling was achieved sl~bsequent to the activation 
of KLH by treatment with /7z-maleimidobenroylsulfo-succinimide 
ester (Pierce and Warringer, Chester, UK). Antiserum SGI which 
identifies the C-terminal decapeptide ofG,Iry and G,2cu and antiserum 
C’S1 which identifies the C-terminal decapcptide of forms of G,oc have 
previously been described [ 10,111. 
Synthetic peptides corresponding to the C-terminal decapeptides of 
G,I/G,2, C;,3, G,, and G, which were used to assess potential cross- 
reaction of antiserum CQ2 with these G-proteins are lsited in Table I 
and were obtained either from Biomac (Glasgow, Scotland) or ac gifts 
from Dr C.G. Unson, Department of Biochemistry, Rockefeller 
Unicer,ity, New York, NY, IJSA. 
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Table I 2 
The C-terminal decapeptldes of the CY subunits of a range of CC 
(;qiGl I QLNLKLYti1.V~COOH 
Cr QNNt_K~lG[.C-t OOH 
G,l KNh’I KDCC;LI.-(‘OOH 
<;,2 liNNl.I<DC‘C;L.~-C‘OOH 
G,3 KNNI KECGLY-(‘OOH 
G, ANNI.R(;C‘C;LY-C‘O(>tl 
The above peptides, with in the CZIW of Gq/<il I an addItional N- 
terminal cysteine were used in competitive LI.ISA’\ \\ith antiwum 
CQ2. (we Fig. I t’or result,). AnalyG~ of the full length pl-edicted 
amino acid xquence~ of the \ariou\ Gpl-oteins ldentificd no other 
peptides In the primary amino acid sequences likel! IO ci-o\\-react with 
1 “\ 
b 
%‘a\ pet-formed as in [S] using a horieiadi\h pel-oxidase (HRP)- 
linked donkey anti-rabbit IgG fraction (Scotri5h .4ntihody Produc- 
tion Unit, Carluke. Scotland) as the secondary antiserum. Visualira- 
[ion of the immunologically detected polypepride ~tias achieved using 
o-diani\idine (Sigma) a\ \ub\trate lot- HRP. 
2.3. ELI.54 
The reacrivit> of antiserum CQ 2 again\1 I ~g of the bat-iou iyn- L 
theric pcptides ~.a$ a\aec\ed by using o-phenqlenediatni~le 
dihydrochloride ai substl-ate l’or HRP-linhed wcondary antIbody. 
(‘olour production \+a~ measuwd at JY2 nm on a 7iterteh Xlultiwan. 
0 
10 100 1000 10000 1 OOOOO 
dilution 
Neuroblastoma x glioma hybrid NGIOX-I 5, Glioma C6 UU I, R~I 
I i’ibroblart and human monocytic 11937 cell\ were sro\\n in tissue 
culture a$ described previously [I?- 111. In wmc case\ cells were 
trcatrd with either pertu\G, toxin (25 ng, ml, I6 h) or cholera toxin (I 
pgirnl, 16 h) prior IO harve\t of the cells. klembl ane\ l’rom these cell\ 
and from rat cerebral cortex welt prepat-ed a\ in [I?]. 
3. RESULTS 
Competitive ELISA of the reacti\,ity of antiserum 
CQ2 against the peptide used for its generation in- 
dicated strong reactivity with half maximal interaction 
recorded at a I:30000 to 1:50000 dilution of the crude 
antiserum (Fig. I). By contrast, equivalent ELISAs with 
this antiserum demonstrated no cross-reactivity with 
synthetic peptides representing the C-terminal decapep- 
tides of the N subunits of Gil, G,2, Gi3, G,, or G, (Fig. 
l), confirming the specificity of this antiserum for the 
C-terminal region of the CY subunit of Gq/G I 1. 
tified a single 42 kDa polypeptide. This polypeptide was 
present, hobvever, at a considerably lower level on a 
protein basis than in the other cell lines tested (Fig. 2). 
No difference in levels of the polypeptide identified by 
antiserum CQ2 was noted between undifferentiated 
U937 cells and U937 cells differentiated by exposure to 
dimethylsulphoxide (1.25Vo (v/l), 72 h) (Fig. 2). 
As one of the first tissue sources used for purification 
of these G-proteins was brain [15], we used antiserum 
CQ2 in immunoblots of rat brain cortical membranes. 
An apparently single polypeptidc of 42 kDa \vas iden- 
tified by this antiserum (Fig. 2). An equivalent polypep- 
tide was detected by antiserum CQ2 in membranes of 
neuroblastoma x glioma hybrid NG108-15 cells, 
glioma C6 BUI cells and Rat 1 fibroblasts (Fig. 2), all 
cell lines which are widely used in studies on pertussis 
toxin-insensitive agonist regulation of the hydrolysis of 
inositol containing phospholipids. lmmunoblotting of 
membranes of U937 cells with antiserum CQ2 also iden- 
It has been noted previously that Gproteins which 
are substrates for pertussis toxin-catalysed ADP- 
ribosylation migrate more slo\vly in SDS-PAGE follow- 
ing this covalent modification (e.g. [16]). Furthermore, 
treatment of cells with cholera toxin substantially 
downregulates the population of G,(Y in cells [ 17-191. 
To confirm that the polypeptide identified by antiserum 
CQ2 was not a substrate for pertussis toxin-catalysed 
ADP-ribosylation, or a form of (;,a, we separated 
membranes of unti-eated and either pertussis toxin or 
cholera toxin-treated rat glioma C6 BUI cells. These 
were subsequently immunoblotted with either an- 
tiserum CQ2 or with antisera SGI which identifies only 
G,2tu in these cells, or CSI which identifies the C- 
terminal region of forms of G,N. Immunorcactivity cor- 
responding to G,2a migrated more slowly following 
pertussis toxin-treatment of the cells but the mobility of 
the polypeptide identified by antiserum CQ2 \vas unaf- 
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Fig. 2. immunological derection of Gqn-/Cl ICY by iln~lullobl~~ttin~ 
membrane fraction, of cells and tissues Hith antiserum CQ2. Mem- 
branes (IS0 fig) from Rat 1 fibrobiasts transfected with the human 
tu2-C 10 adrcnergic receptor (clone 1 C) [ 131 (I), giiorna C6 BLI I cells 
(Z), D,\;ISO-differenriatecl U937 cells (3), undifferentiated lJ937 cells 
(4), neuroblastoma x glioma hybrid NGlO8-15 cells (5) and rat 
cerebral cortex (6) were resolved on SDS-PAGE (IWu (N/V) 
acrylamide) and immunoblotted using antiserum CQ2 (I :200 dilution) 
as the primary antiserum. 
1 23 123 123 
Fig. 3. The CQ2 immunoreactive polypeptide of rat glioma C6 BUl 
cells is not a substrate for pertusris toxin-catalysed ADP-rihosylation 
and is not downrcgulated by cholera toxin treatment of the cells. 
Membranes (panel A, 20 pg, panel B, 100 fig, panel C, 30 gg) from rat 
glioma C6 BUl cells which were either untreated (1) or had been 
pretreated \vith either pertussis toxin (25 ng/ml, 16 h) (2) or with 
cholera toxin (1 &ml. 16 h) (3) were resolved on SDS-PAGE and im- 
munoblotted with antiserum SGI (panel A) to detect G,Zcu, with an- 
tiserum CQ2 (panel H) to detect GqrviGl icu or with antiserum CSI 
(panel C) to detect G\Ly. 
\i’& 
123 123 
Fig. 4. CQ2 immunoreoctivity in U937 cells is not due to crabs- 
reactivity of the antiserum with a pertussis tovn-sensitive G-protein. 
Membranes from 11937 cells which were tither untreated (1 and 3) or 
pretreated %ith pertussis toxin (25 npiml, 16 h) (2) were resolved by 
SDS-PAGE and imlnu~~oblotted with either antiserum SGl (panel A) 
or antiserum CQZ (panel B) (see legend to Fig. 3 for details). The 
mobility of the CQ2 immtcnoreactive polypeptide was not modified 
by pertussis toxin treatment of’ the cells whilst all of the SG I im- 
munoreactive polypeptide migrated more \lowlp in the pel folhxing 
this treatment. 
fected by such treatment (Fig. 3). Furthermore no 
reduction in levels of the polypeptide identified by an- 
tiserum CQ2 was noted following cholera toxin treat- 
ment of the cells whilst levels of G\N were substa~~tially 
reduced (Fig. 3) as has previously been recorded 1191. 
To confirm that the polypeptide identified by antiserum 
CQ2 in U937 cells was not a pertussis toxin-sensitive G- 
protein to which the antiserum displayed weak cross- 
reactivity we immunoblotted membranes of untreated 
and pertussis toxin-pretreated U937 cells with either an- 
tiserum SGl to identify G,2a or with antiserum CQ2. 
Gi2a migrated more slowly through SDS-PAGE 
following pertussis toxin treatment (Fig. 4) but the 
mobility of the CQ2 immunoreacti\:e polypeptide in 
U937 cells was not altered by this treatment (Fig. 4) con- 
firming the presence of Gq/GI 1 in these cells and con- 
clusively demonstrating that this reactivity was not due 
to interaction with one of the pertussis toxin-sensitive 
G-proteins identified previously in these cells. 
4. DISCUSSION 
The recent use of polymerase chain reaction (PCR) 
technology [20] and the isolation of cDNA’s [7] has 
identified a new subfamily of G-protein cy subunits 
173 
which are unlikely to be substrates for either pcrtuasis 
or cholera toxin-catalysed ADP-ribosylation. This has 
led to intense speculation as to whether one or more of 
these G-proteins corresponds to G,-,, the proposed C- 
protein responsible for pertuasis toxin-insensitive recep- 
tor regulation of a phorphoinositidase C. These G- 
proteins migrate as 42 kDa polypeptidcs on SDS-PAGE 
and partial sequence analysis indicated that they may 
\bcell correspond to the product of the Gym and/or the 
G I la gene [8,9,15]. Thei;e two G-proteins are 88o;h 
identical in overall primary sequence but differ in only 
4 of the C-terminal 144 amino acids. As this C-terminal 
region is believed to define both receptor and effector 
interactions with the G-protein it would not be surpris- 
ing if these polypeptide\ had wry similar functions. The 
ai,ailabilit): of antisera with defined specificity against 
these proteins will be of considerable use in the 
definitive characterization of the role(s) of these G- 
proteins. 
Antiserum CQ2 sho\f:ed no detectable cross-reactivity 
against peptides ~orre~poIlding to the eqLii~ale]i~ region 
of a wide variety of other G-proteins (Table I), in- 
cluding thaw which are wbstratec for the ,4DP- 
ribosgltransferase activity of pertussis tosin, indicating 
that this antiserum is highly specific for Gq/Gll. Fur- 
thermore, based on the predicted C-terminal heptapep- 
tides ofGl2, G13, G15 and Gl6 1211 we predict that an- 
tiserum CQ2 will also fail to cros+react with any of 
these polypeptides. 
W’e note thar Ciq/Cill immunoreactivity is widely ev 
pressed as predicted by analysis of the presence of their 
mRNA’s 171. This is consistent with predictions for C- 
proteins involved in receptor regulation of pho~~~hoino- 
citidase C. :Lloreover, iniinunodet~~tion with alltiseruni 
CQ2 demonstrates clearly that Gq/GI I do not display 
any mobility shift in SDS-PAGE following treatment of 
cells l++th pertussis toxin (Figs. 3 and 4). By im- 
munoblotting with antiserum CQ2 we have detected a 
42 kDa polypeptide in a range of cell types including the 
neuroblastoma x glioma hybrid NC; 108-l 5, glioma 
C6BU1, Rat 1 fibroblasts and also human U937 cells. 
Stimulation of inositot phosphate production in U937 
cells by Ihe chemotactic pcptidc ,R;-formyl-methion!l- 
leucyl-phcnflalanine (FMLP) is prevented by prior es- 
posure of the cells to pertussis toxin [ 131 iIldi~atir1~ that 
the relevant G-protein is a substrate for pertussis toxin- 
catalysed ADP-ribosylation. As such, Gq/GI 1 prc- 
sumably cannot be involved in transducing the effects 
of’ FMLP. However, phosphoinositide metabolism in 
11937 cells stimulated by platelet activating factor is not 
scnsitiw to treatment of the cells with pertussia toxin 
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[22] and as ruch Gq/G t 1 may be important for this pro- 
c e $5 I
We tu\,e pre\iously generated a selection of antipep- 
tide antisera against the predicted C-terminal decapep- 
tide sequences of G,2, G,, and G, and used these antisera 
to prevent receptori(;-protein contacts [3,5.23,24]. We 
hope that the antiserum described in this study will be 
~tsef‘ul to define conclusively if Gq and/or G 1 I regulate 
receptor control of the generation of lil~id-~leri~ed 
vxondary messengers in l~ertlleabili~e~i cells and native 
membtanc systemi; as lye11 as in re~~~tlstit~l~i~e assays. 
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